Software services company Zensar Technologies is poised for the second phase of growth with focus on making it a 100% digital firm, Sandeep Kishore, who took charge as the company’s new CEO and managing director on February 15, told TOI on Tuesday .Kishore replaces Ganesh Natarajan, the founder of the company , whose term will end on April 30.
Sandeep Kishore is set to take charge from Ganesh Natarajan as managing director and chief executive of Zensar Technologies, information technology arm from the RPG Group. Natarajan had taken it from a Rs 40-crore entity to a Rs 2,000-plus crore enterprise. Kishore, an old hand at HCL Technologies, tells Shivani Shinde Nadhe why he choose to join Zensar, his growth strategy and how he intends to leverage the presence of Apax Partners.
Zensar Technologies Ltd, an RPG Enterprises’ group company, named Sandeep Kishore as chief executive officer and managing director. Kishore will join Zensar on 12 January and take over leadership of the company from Ganesh Natarajan, whose term comes to an end on 30 April 2016. e will be based in San Jose, California, Zensar said in a statement on Monday. An alumnus of IIT Bombay, Kishore has over 25 years of experience in the IT industry, spanning across IT services, engineering and business process outsourcing.
“Regardless of the type of business (digital agencies, systems integrators, consultants), today’s service providers are successful because they have a mindset of solving their clients’ problems, rather than merely offering solutions. To succeed, service providers need to act as an extension of the client’s team. They are constantly having to balance both moving forward with daily tasks and demonstrating their value to the client in order to solidify the relationship.”
IIT Bombay Heritage Foundation & IIT Bombay Alumni Association’s Author of the Month – Sandeep Kishore
“Although I have been writing Hindi poems for over 30 years, it is only recently that I decided to select a few of them and publish them in a book […] to raise awareness and funds towards the Skill Development and Vocational Training Programs that our foundation is committed towards. […] [The] net proceeds from this book will be donated to the cause of skill development and vocational training programs and will be donated through Har Asha Foundation, a non-profit organization that provides support to youth in this sector.”
“The middle of this decade is here. Much has been achieved in the first half and much more is expected from the second. While there are several key areas of focus which deserve attention and can create impact as we look into the next five years, the following five [… have] the mega potential to transform the world.”
EnterpriseAppsTech publishes Enter the chief digital officer: Creating a roadmap to the enterprise of the future
“Everywhere you look, businesses are being rejuvenated and reinvented, utilising new technologies and tools in an effort to tap into the digital advantage. This process of digitalisation is as unstoppable as it is irreversible; organisations are investing heavily to stay afloat in the new digital age. As such, digitalisation has moved way beyond high-concept discussions at the board level, to the creation of detailed roadmaps and the implementation of new ways of working and service delivery.”
“The era of “Digital Darwinism” is upon us[…] Businesses today have no choice but to adopt digital technologies or run the risk of being left in the digital dust by native digital companies which simply understand technology better and have deployed it more quickly and more effectively.”
“We are proud to be associated with Merck & Co. The last 10 years have been a rewarding journey with Merck & Co. It is exciting to see this relationship grow beyond the contract and where we have been able to deliver unique value consistently[…] Our relationship with Merck has played a key role in HCL’s evolution as an integrated service provider and leader in Life Sciences and Healthcare space.”
“Big data and predictive real-time analytics are critical dimensions of technology which have wide applicability across industries. IDC forecasts the big data technology and services market to become a USD 41.5 billion business through 2018. This market is growing with a CAGR of six times faster than the overall IT market and the growth rate of data and information has been incredible. As per IBM, 2.5 quintillion bytes of data is generated every day from the internet, posts on social media sites, emails, ecommerce transactions, website contents, videos, digital photos, sensors and more. All this, with only 41% of the world connected to the internet. Imagine the colossal amount of data that will be generated when the entire world is online and hundreds of billion devices become connected through the Internet of Things, IoT.”
“Everywhere you look businesses are being reinvented and rejuvenated, utilising new technologies and tools in an effort to tap into the digital advantage. This process of digitalisation is as unstoppable as it is irreversible; businesses are investing heavily to stay afloat in the new digital age. As such, digitalisation has moved way beyond high-concept discussions at the board level, to the creation of detailed roadmaps and the implementation of new ways of working and service delivery.”
“If you look around, it is easy to see every facet of our lives – both personal and professional – being impacted by software. Software is pivotal to the growth of most new and emerging industry segments and it has transformed mature industries such as agribusiness, mining, construction, industrial manufacturing, automotive and aerospace. The healthcare industry is no exception.”
HCL Technologies Achieves Life Sciences Competency Status in the AWS Partner Network Competency Program
“Achieving the AWS Life Sciences Competency is a strong validation of HCL’s continued commitment to developing innovative new solutions that create value for our life sciences customers in what has become a very complex and rapidly evolving environment […] By teaming up with AWS, we’ve been able to more effectively help life sciences customers conduct drug research and development with a main focus on science and patients.”